# The histological and radiological evaluation of autologous peripheral venous blood concentrates in socket preservation: a systematic review and meta-analysis

**Authors:** Yusheng Meng, Min Wu, Shuang Wang, Xiuqiao Yang, Yun Liu

PMC · DOI: 10.3389/fdmed.2025.1602738 · Frontiers in Dental Medicine · 2025-07-11

## TL;DR

This study finds that using autologous peripheral venous blood concentrates helps preserve bone in tooth sockets and promotes new bone growth.

## Contribution

The study provides new evidence that APVBCs reduce bone resorption and enhance bone formation in socket preservation.

## Key findings

- APVBCs significantly reduced vertical bone resorption in the buccal and palatal/lingual ridges.
- Newly formed bone percentage increased significantly with APVBCs during socket preservation.
- Combining APVBCs with materials improved osteogenic efficiency but had no effect on remaining graft particles.

## Abstract

A detailed meta-analysis and systematic search was conducted to assess the histologic and radiographic efficacy of autologous peripheral venous blood concentrates (APVBCs) for the socket preservation.

Electronic databases were searched until 31 January 2025. Randomized controlled trials (RCTs) and controlled clinical trials (CCTs) in English were identified. Alveolar bone reconstruction was assessed through histologic and radiographic evaluation after tooth extraction. Data were analyzed using Revman5.3, and the risk of bias was evaluated with the Cochrane Collaboration tool.

A total of 16 studies (12 RCTs and 4 CCTs) involving 619 sites was included in our meta-analysis. The results indicated that the APVBCs application significantly reduced the vertical bone resorption in the buccal ridge (standardized mean difference [SMD]: −0.30; 95% confidence interval [CI]: −0.54 to −0.06; p = 0.02, I2 = 5%) and palatal/lingual ridge (SMD:−0.30, 95% CI: −0.54 to −0.06; p = 0.02, I2 = 0%) by radiographic analysis. In addition, the vertical resorption of the buccal and palatal/lingual alveolar ridge was significantly reduced by using materials combined with APVBCs as the filling material for extraction sockets. The newly formed bone percentage showed a statistically significant increase in APVBC presence during socket preservation (SMD: 1.27, 95% CI: 0.65–1.89; p < 0.0001, I2 = 71%) and APVBC + material groups (SMD: 0.85, 95% CI: 0.35–1.35; p = 0.0009, I2 = 0%). However, APVBCs + materials did not show significant effects on the remaining graft particles.

APVBCs in socket preservation can reduce vertical bone resorption and enhance new bone formation. Meanwhile, APVBCs may improve osteogenic efficiency with bone graft material.

https://www.crd.york.ac.uk/PROSPERO/view/CRD420250653020, identifier CRD420250653020.

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 281572] {aka VEGF, VEGF-A, VPF, eVEGF120, eVEGF164}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, BGLAP (bone gamma-carboxyglutamate protein) [NCBI Gene 281646] {aka BGP}, RUNX2 (RUNX family transcription factor 2) [NCBI Gene 536911], COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 282187], FGF1 (fibroblast growth factor 1) [NCBI Gene 281160] {aka ECGF, EDGF, EDGF II, FGF-1, FGF2B, HBGF-1}
- **Diseases:** alveolar bone defects (MESH:D016301), inflammatory (MESH:D007249), APVBC (MESH:D006402), oral diseases (MESH:D009059)
- **Chemicals:** BBM (-), oxygen (MESH:D010100), hyaluronic acid (MESH:D006820)
- **Species:** Homo sapiens (human, species) [taxon 9606], Bos taurus (bovine, species) [taxon 9913]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12289649/full.md

## Figures

15 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12289649/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12289649/full.md

---
Source: https://tomesphere.com/paper/PMC12289649